Relationship between CDCA8 and tumor progression as well as that between CDCA8 and stemness maintenance of stem cells

doi:10.3760/cma.j.cn371439-20201012-00043

Abstract

Abstract:

Cell division cycle associated 8 (CDCA8) is involved in the accurate regulation of cell division cycle. The expression change of CDCA8 can affect the progression of many kinds of tumors as well as the prognosis of patients. In recent years, studies have suggested that CDCA8 may play an important role in maintaining the stemness of cancer stem cells. Exploring the mechanism of CDCA8 affecting tumor is of great significance for the diagnosis and treatment of tumors.

Key words: Neoplasms, Neoplastic stem cells, Cell division cycle associated 8, Mechanism

Wei Yongjian, Hu Jinjing, Li Xun. Relationship between CDCA8 and tumor progression as well as that between CDCA8 and stemness maintenance of stem cells[J]. Journal of International Oncology, 2021, 48(4): 216-219.

References 28

[1]	Pan S, Zhan Y, Chen X, et al. Identification of biomarkers for controlling cancer stem cell characteristics in bladder cancer by network analysis of transcriptome data stemness indices[J]. Front Oncol, 2019, 9:613. DOI: 10.3389/fonc.2019.00613. doi: 10.3389/fonc.2019.00613
[2]	Phan NN, Wang CY, Li KL, et al. Distinct expression of CDCA3, CDCA5, and CDCA 8 leads to shorter relapse free survival in breast cancer patient[J]. Oncotarget, 2018, 9(6):6977-6992. DOI: 10.18632/oncotarget.24059. doi: 10.18632/oncotarget.v9i6
[3]	Yu D, Shi L, Bu Y, et al. Cell division cycle associated 8 is a key regulator of tamoxifen resistance in breast cancer[J]. J Breast Cancer, 2019, 22(2):237-247. DOI: 10.4048/jbc.2019.22.e29. doi: 10.4048/jbc.2019.22.e29
[4]	张路遥, 黄辉星, 曹立环, 等. CDCA8和INCENP mRNA在肝细胞癌组织中的表达及其临床意义[J]. 中国肿瘤生物治疗杂志, 2017, 24(2):158-167. DOI: 10.3872/j.issn.1007-385X.2017.02.010.
[5]	Bi Y, Chen S, Jiang J, et al. CDCA8 expression and its clinical relevance in patients with bladder cancer[J]. Medicine (Baltimore), 2018, 97(34): e11899. DOI: 10.1097/MD.0000000000011899. doi: 10.1097/MD.0000000000011899
[6]	Gao X, Wen X, He H, et al. Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells[J]. Peer J, 2020, 8:e9078. DOI: 10.7717/peerj.9078. doi: 10.7717/peerj.9078
[7]	Dai C, Miao CX, Xu XM, et al. Transcriptional activation of human CDCA8 gene regulated by transcription factor NF-Y in embryonic stem cells and cancer cells[J]. J Biol Chem, 2015, 290(37):22423-22434. DOI: 10.1074/jbc.M115.642710. doi: 10.1074/jbc.M115.642710
[8]	Fu G, Xu Z, Chen X, et al. CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation[J]. J Cancer, 2020, 11(9):2408-2420. DOI: 10.7150/jca.35372. doi: 10.7150/jca.35372
[9]	Bu Y, Shi L, Yu D, et al. CDCA 8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells[J]. Gene, 2019, 703:1-6. DOI: 10.1016/j.gene.2019.04.006. doi: 10.1016/j.gene.2019.04.006
[10]	Chang JL, Chen TH, Wang CF, et al. Borealin/Dasra B is a cell cycle-regulated chromosomal passenger protein and its nuclear accumulation is linked to poor prognosis for human gastric cancer[J]. Exp Cell Res, 2006, 312(7):962-973. DOI: 10.1016/j.yexcr.2005.12.015. doi: 10.1016/j.yexcr.2005.12.015
[11]	Date DA, Jacob CJ, Bekier ME, et al. Borealin is repressed in response to p53/Rb signaling[J]. Cell Biol Int, 2007, 31(12):1470-1481. DOI: 10.1016/j.cellbi.2007.06.013. doi: 10.1016/j.cellbi.2007.06.013
[12]	Hindriksen S, Lens SMA, Hadders MA. The ins and outs of aurora B inner centromere localization[J]. Front Cell Dev Biol, 2017, 5:112. DOI: 10.3389/fcell.2017.00112. doi: 10.3389/fcell.2017.00112 pmid: 29312936
[13]	Jiao DC, Lu ZD, Qiao JH, et al. Expression of CDCA8 correlates closely with FOXM1 in breast cancer: public microarray data analysis and immunohistochemical study[J]. Neoplasma, 2015, 62(3):464-469. DOI: 10.4149/neo_2015_055. doi: 10.4149/neo_2015_055 pmid: 25866227
[14]	Hélias-Rodzewicz Z, Lourenco N, Bakari M, et al. CDKN2A depletion causes aneuploidy and enhances cell proliferation in non-immortalized normal human cells[J]. Cancer Invest, 2018, 36(6):338-348. DOI: 10.1080/07357907.2018.1491588. doi: 10.1080/07357907.2018.1491588
[15]	Bi N, Sun Y, Lei S, et al. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol associated hepatocellular carcinoma using weighted gene co expression network analysis[J]. Oncol Rep, 2020, 44(2):611-627. DOI: 10.3892/or.2020.7634. doi: 10.3892/or
[16]	Wang X, Song P, Huang C, et al. Weighted gene co expression network analysis for identifying hub genes in association with prognosis in Wilms tumor[J]. Mol Med Rep, 2019, 19(3):2041-2050. DOI: 10.3892/mmr.2019.9881.
[17]	Wei W, Lv Y, Gan Z, et al. Identification of key genes involved in the metastasis of clear cell renal cell carcinoma[J]. Oncol Lett, 2019, 17(5):4321-4328. DOI: 10.3892/ol.2019.10130.
[18]	Xu N, Chen SH, Lin TT, et al. Development and validation of hub genes for lymph node metastasis in patients with prostate cancer[J]. J Cell Mol Med, 2020, 24(8):4402-4414. DOI: 10.1111/jcmm.15098. doi: 10.1111/jcmm.v24.8
[19]	Song Z, Huang Y, Zhao Y, et al. The identification of potential biomarkers and biological pathways in prostate cancer[J]. J Cancer, 2019, 10(6):1398-1408. DOI: 10.7150/jca.29571. doi: 10.7150/jca.29571
[20]	Ci C, Tang B, Lyu D, et al. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis[J]. Int J Mol Med, 2019, 43(1):404-412. DOI: 10.3892/ijmm.2018.3985.
[21]	Yue L, Li L, Li D, et al. High-throughput screening for Survivin and Borealin interaction inhibitors in hepatocellular carcinoma[J]. Biochem Biophys Res Commun, 2017, 484(3):642-647. DOI: 10.1016/j.bbrc.2017.01.160. doi: 10.1016/j.bbrc.2017.01.160
[22]	Li B, Liu B, Zhang X, et al. KIF18B promotes the proliferation of pancreatic ductal adenocarcinoma via activating the expression of CDCA8[J]. J Cell Physiol, 2020, 235(5):4227-4238. DOI: 10.1002/jcp.29201. doi: 10.1002/jcp.v235.5
[23]	Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy[J]. J Cell Physiol, 2019, 234(6):8381-8395. DOI: 10.1002/jcp.27740. doi: 10.1002/jcp.v234.6
[24]	徐贺龙, 李燕, 任程晖, 等. 利用加权基因共表网络识别肝细胞癌干细胞相关基因的研究[J]. 中国普外基础与临床杂志, 2020, 27(5):560-568. DOI: 10.7507/1007-9424.202001067.
[25]	Zhao M, Chen Z, Zheng Y, et al. Identification of cancer stem cell-related biomarkers in lung adenocarcinoma by stemness index and weighted correlation network analysis[J]. J Cancer Res Clin Oncol, 2020, 146(6):1463-1472. DOI: 10.1007/s00432-020-03194-x. doi: 10.1007/s00432-020-03194-x
[26]	Li W, Lee MR, Choi E, et al. Clinicopathologic significance of survivin expression in relation to CD133 expression in surgically resected stage Ⅱ or Ⅲ colorectal cancer[J]. J Pathol Transl Med, 2017, 51(1):17-23. DOI: 10.4132/jptm.2016.09.23. doi: 10.4132/jptm.2016.09.23
[27]	Comisso E, Scarola M, Rosso M, et al. OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness[J]. Oncogene, 2017, 36(30):4253-4266. DOI: 10.1038/onc.2017.20. doi: 10.1038/onc.2017.20 pmid: 28319064
[28]	Ding H, Wang Y, Zhang H. CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-fluorouracil resis-tance in hepatocellular carcinoma[J]. J Pharmacol Sci, 2020, 143(3):219-225. DOI: 10.1016/j.jphs.2020.04.006. doi: 10.1016/j.jphs.2020.04.006